Recent News for PER - Percheron Therapeutics Limited

Date	Title
Mar 7	Percheron Therapeutics continues to advance Duchenne treatment
Feb 29	Shareholders have faith in loss-making Percheron Therapeutics (ASX:PER) as stock climbs 26% in past week, taking five-year gain to 142%